AKT gene amplification (common in AKT1) is more prevalent in BC [18], and 2.5% of AKT1 proteins have E17K mutations in the PHD structural region, resulting in aberrant AKT1 activation [19]. This evidence concerns the gene AKT1 and breast cancer.